Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Filings indexed 377 across all filing types
Latest filing 2023-09-11 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
2023 09 11 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between September 4, 2023, and September 8, 2023, including daily transaction tables. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2023-09-11 Italian
2023 09 04 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between August 28, 2023, and September 1, 2023. It provides daily transaction summaries and detailed transaction logs. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2023-09-04 Italian
Allegato 3F - Agosto 2023
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Model Disclosure for Transactions in the Issuer's Securities). It details transactions (purchases/sales) in the company's own shares (PHILOGEN S.p.A.) occurring between August 1st and August 16th, 2023. This structure and content specifically relate to insider trading or transactions by directors/executives in the issuer's securities. Reviewing the definitions, 'Director's Dealing' (Code: DIRS) is the most appropriate category for reporting personal share transactions by company directors and executives (insider trades). Although the document reports transactions by the Issuer itself in Section 1, the format strongly suggests a regulatory filing related to insider activity or share transactions, which aligns best with DIRS or POS. Since the document details transactions in the issuer's securities, and the structure is a formal disclosure schema, DIRS (Director's Dealing) is a strong fit if these are insider transactions, or POS (Transaction in Own Shares) if the issuer is buying back its own stock. Given the context of 'SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI' which often covers insider dealings, DIRS is selected as the primary classification for executive/director transactions, although POS is also relevant for issuer share repurchases. Since the document details transactions in the issuer's securities, and the structure is a formal disclosure schema, DIRS (Director's Dealing) is the most specific fit for reporting executive/insider transactions, which this schema is designed for.
2023-09-04 Italian
2023 08 28 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between August 21, 2023, and August 25, 2023, including daily transaction logs. This activity directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for Transaction in Own Shares (Code: POS). The document is a detailed report of transactions, not just an announcement of a report, and its length (13,348 chars) suggests it is the primary disclosure, not a brief RPA.
2023-08-28 Italian
2023 08 21 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. between August 14, 2023, and August 18, 2023, including daily transaction logs and total holdings. This activity directly corresponds to the definition of a company reporting transactions involving its own shares. Reviewing the filing definitions: - 10-K/IR/ER/MRQ/AR are financial reports, which this is not. - DIRS (Director's Dealing) is for executive/director personal trades, not company buybacks. - The most appropriate category is 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance by the company itself.
2023-08-21 Italian
2023 08 14 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between August 7, 2023, and August 11, 2023. It provides daily transaction summaries and the total number of shares held after the transactions. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate code is POS.
2023-08-14 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.